HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES

Sharifi, Nima; Azad, Arun A.; Patel, Mona; Hearn, Jason W. D.; Wozniak, Michele; Zohren, Fabian; Sugg, Jennifer; Haas, Gabriel P.; Stenzl, Arnulf; Armstrong, Andrew J.

dc.contributor.author	Stenzl, Arnulf
dc.date.accessioned	2025-01-28T09:43:17Z
dc.date.available	2025-01-28T09:43:17Z
dc.date.issued	2024
dc.identifier.issn	2666-3791
dc.identifier.uri	http://hdl.handle.net/10900/161239
dc.language.iso	en	de_DE
dc.publisher	Cambridge : Cell Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.xcrm.2024.101644	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_00306
utue.personen.roh	Sharifi, Nima
utue.personen.roh	Azad, Arun A.
utue.personen.roh	Patel, Mona
utue.personen.roh	Hearn, Jason W. D.
utue.personen.roh	Wozniak, Michele
utue.personen.roh	Zohren, Fabian
utue.personen.roh	Sugg, Jennifer
utue.personen.roh	Haas, Gabriel P.
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Armstrong, Andrew J.
dcterms.isPartOf.ZSTitelID	Cell Reports Medicine	de_DE
dcterms.isPartOf.ZS-Issue	Article 101644	de_DE
dcterms.isPartOf.ZS-Volume	5 (8)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE